The Food and Drug Administration wants ViroPharma Inc. to conduct an additional clinical study of its experimental angiodema drug Cinryze before the agency will render a decision on the company’s supplemental biologics license application. (VPHM)
National Business News - Local Business News | bizjournals, Biz Journals
Thu, 06/04/2009 - 7:26am
The Food and Drug Administration wants ViroPharma Inc. to conduct an additional clinical study of its experimental angiodema drug Cinryze before the agency will render a decision on the company’s supplemental biologics license application. (VPHM)